| 英文别名： |
Rapamycin,42-deoxy-42-(1H-tetrazol-1-yl)-, (42S)-;Zotarolimus;zotarolimus(ABT-578);A179578;A-179578;ABT578;ABT-578;(42S)-42-Deoxy-42-(1H-tetrazol-1-yl)rapamycin;Resolute;42-(1-Tetrazolyl)rapamycin;ZOTAROLIMUS [USAN];ABT 578;ZOTAROLIMUS [INN];BDBM50174276;GTPL7974;Rapamycin, 42-deoxy-42-(1H-tetrazol-1-yl)-, (42S)-;Zotarolimus; ABT-578;SCHEMBL67389;UNII-H4GXR80IZE;EX-A2216;DTXSID50873387;ZOTAROLIMUS [WHO-DD];HY-12424;Zotarolimus, >90%;s7091;NCGC00386351-01;(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-12-[(2R)-1-[(1S,3R,4S)-3-methoxy-4-(1H-1,2,3,4-tetrazol-1-yl)cyclohexyl]propan-2-yl]-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0^{4,9}]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone;221877-54-9;AKOS037645037;ZOTAROLIMUS [MART.];Endeavor;CS-5715;H4GXR80IZE;CHEBI:135897;Zotarolimus (ABT-578);Mdt-4107;CHEMBL219410;A 179578;Q15410168;MFCD09752954;Zotarolimus [USAN:INN];CCG-270596;J-014574;zotarilumus;AS-56346;AC-31528 |
沪公网安备31011402010658号 
